Searched for
BIOPHARMA SHAKTI
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...- Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- J&K attracts record ₹5,824 crore investment in 2025-26, 13x jumpJammu and Kashmir has achieved a record investment of over ₹5,800 crore in 2025-26. This marks a significant jump, thirteen times higher th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- FM Nirmala Sitharaman to push biopharma, semiconductor missions in NorwayFinance Minister Nirmala Sitharaman is in Oslo to boost India's bio-pharma and semiconductor sectors. She will meet Norwegian Prime Ministe...
- Biopharma Shakti: India targets China dependence, patent cliffIndia is launching a major initiative to boost its biopharmaceutical manufacturing. This plan aims to reduce reliance on China for crucial ...
- Biocon's Shaw says Budget boosts India’s health and innovation agendaThe Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sect...
- Budget 2026: Manufacturing push, PLI schemes boost domestic productionIndia's new budget champions manufacturing, aiming to significantly increase its contribution to the nation's GDP. Key sectors like semicon...
- Budget 2026 gives biologics & biosimilars a major policy boostIndia is set to become a global biopharmaceutical manufacturing hub. Finance Minister Nirmala Sitharaman announced a dedicated ₹10,000 cror...
- Budget to boost economy, enhance India's global competitiveness: India IncIndia Inc has welcomed the Union Budget 2026-27. Industry leaders believe it is a budget for the real economy. It focuses on enhancing Indi...
- Biopharma Shakti programme key enabler for India's journey towards value leadership: Dr Reddy''s LabWith its 2026 Union Budget, India places a spotlight on the future of healthcare, specifically targeting biologics and biosimilars. A visio...
- Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...
- Union Budget 2026: Govt to overhaul drug regulator CDSCO, announces Rs 10,000 crore ‘Biopharma Shakti’ pushIndia Budget 2026: India's drug regulatory authority, CDSCO, will be strengthened to meet global standards and speed up approvals. A new in...
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...
- Budget 2026: Max Healthcare, Apollo Hospitals, other stocks rise up to 4% as FM boosts medical tourismIndian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...
- Budget 2026: Finance Minister proposes 5 medical tourism hubsFinance Minister Nirmala Sitharaman announced plans for five regional medical tourism hubs. A Rs 10,000 crore Biopharma Shakti program will...
- Budget 2026: Sitharaman proposes Rs 10,000-crore Biopharma Shakti scheme to boost biopharma manufacturingThe proposed fund aims to position India as a global biopharma manufacturing hub
- Budget 2026: Sitharaman’s six-point plan to propel India’s next growth phaseUnion Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...
Load More
